Pfizer India shares rose after the its US parent company struck a deal with the Trump administration to sell key medicines at steep discounts through a new federal website. Speaking at the White House, Trump said Pfizer agreed to supply several of its drugs at 'heavily discounted prices,' allowing patients to pay cash directly on the new TrumpRX website.